Valuation: Lonza Group AG

Market Cap 46.96B 57.62B 51.34B 42.77B 80.62B 5,445B 82.79B 564B 226B 2,884B 216B 212B 9,100B P/E 2026 *
39.2x
P/E 2027 * 32.8x
Enterprise Value 49.37B 60.58B 53.98B 44.97B 84.76B 5,725B 87.04B 593B 237B 3,032B 227B 222B 9,567B EV / Sales 2026 *
6.93x
EV / Sales 2027 * 6.2x
Free-Float
99.36%
Yield 2026 *
0.83%
Yield 2027 * 0.95%

Last Transcript: Lonza Group AG

1 day+1.63%
1 week+4.93%
Current month+4.38%
1 month+16.98%
3 months+19.77%
6 months+37.17%
Current year+25.03%
1 week 638.4
Extreme 638.4
674
1 month 563.4
Extreme 563.4
674
Current year 454.6
Extreme 454.6
674
1 year 454.6
Extreme 454.6
674
3 years 315.6
Extreme 315.6
674
5 years 308.6
Extreme 308.6
771.6
10 years 156.2
Extreme 156.2
785.4
Manager TitleAgeSince
Chief Executive Officer 54 2024-06-30
Director of Finance/CFO 54 2021-11-30
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Director/Board Member 67 2016-04-25
Director/Board Member 66 2018-05-03
Director/Board Member 60 2022-05-04
Date Insider Type Main position Quantity % Market Cap. Importance
5/8/26 Buy 460 0.0007%
5/8/26 Buy 618 0.0009%
3/11/26 Sell 179 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.63%+4.93%+24.89%+104.31% 57.62B
+3.80%+8.10%+63.78%+77.70% 69.4B
+0.07%+1.39%+12.75%+75.17% 57.24B
+0.41%-3.70%+26.06%+34.32% 43.65B
+2.51%+4.22%+20.49%+110.71% 44.03B
-11.04%-6.63%+199.38%+701.67% 38.08B
+7.50%+13.58%+29.07%+64.46% 36.31B
+1.59%-4.04%+97.66%+79.95% 32.61B
-2.96%+6.29%+35.09%-5.63% 25.47B
-1.13%-2.54%-41.80%+337.67% 23.86B
Average +0.25%+4.10%+46.74%+158.03% 42.83B
Weighted average by Cap. +0.69%+4.02%+47.54%+143.97%

Financials

2026 *2027 *
Net sales 7.13B 8.74B 7.79B 6.49B 12.23B 826B 12.56B 85.61B 34.23B 438B 32.82B 32.11B 1,381B 7.95B 9.75B 8.69B 7.24B 13.64B 921B 14.01B 95.45B 38.17B 488B 36.59B 35.8B 1,540B
Net income 1.22B 1.49B 1.33B 1.11B 2.09B 141B 2.15B 14.64B 5.85B 74.81B 5.61B 5.49B 236B 1.43B 1.75B 1.56B 1.3B 2.45B 165B 2.51B 17.14B 6.85B 87.6B 6.57B 6.43B 276B
Net Debt 2.41B 2.96B 2.64B 2.2B 4.14B 280B 4.25B 28.96B 11.58B 148B 11.1B 10.86B 467B 2.28B 2.8B 2.49B 2.08B 3.92B 265B 4.02B 27.41B 10.96B 140B 10.51B 10.28B 442B
Projected Income Statement - Annual - Lonza Group AG
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
20,141
Date Price Change Volume
26-11-05 CHF 672.40 +1.63% 208,723
26-11-04 CHF 661.60 +1.44% 196,877
26-11-03 CHF 652.20 +0.62% 167,644
26-11-02 CHF 648.20 +0.62% 130,179
26-10-30 CHF 644.20 +0.53% 179,769
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Lonza Group AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
672.40CHF
Average target price
705.30CHF
Spread / Average Target
+4.89%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Lonza Group AG
  1. Stock Market
  2. Stocks
  3. LONN Stock